🔗 Permalink

Inventor profile of:

Daniel Offen

City:

Kfar HaRoe

Country:

Israel

Published Applications:

Last publication date:

2021-07-15

Top Assignees for applications by Daniel Offen

The entities that hold a legal rights for patent applications filed by inventor Offen Daniel:

Ramot at Tel-Aviv University Ltd. 15 Tel-Aviv, Israel
BrainStorm Cell Therapeutics Ltd. 3 Petach-Tikva, Israel
YEDA RESEARCH AND DEVELOPMENT CO. LTD. 1 Rehovot, Israel
RAMOT AT TEL AVIV UNIVERSITY 1 Tel Aviv, Israel
BrainStorm Cell Therapeutics Inc. 1 Petach-Tikva, Israel
Ramot At Tel Aviv University Ltd. 1 Tel-Aviv, IL United States

Recent patent applications by Offen Daniel

Daniel Offen from Kfar HaRoe, IL has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-07-15

US20210214699A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MODULATING MYELOPEROXIDASE (MPO) EXPRESSION

#2 | 2021-04-29

US20210121539A1

Human necessities

METHODS AND COMPOSITIONS FOR MODULATING MYELOPEROXIDASE (MPO) EXPRESSION

#3 | 2020-09-10

US20200283849A1

Chemistry; metallurgy

METHODS FOR GENDER DETERMINATION OF AVIAN EMBRYOS IN UNHATCHED EGGS AND MEANS THEREOF

#4 | 2020-05-14

US20200149063A1

Chemistry; metallurgy

METHODS FOR GENDER DETERMINATION AND SELECTION OF AVIAN EMBRYOS IN UNHATCHED EGGS

#5 | 2019-01-31

US20190029236A1

Human necessities

METHODS FOR GENDER DETERMINATION OF AVIAN EMBRYOS IN UNHATCHED EGGS AND MEANS THEREOF

#6 | 2015-10-15

US20150290298A1

Human necessities

Combination treatment for amyotrophic lateral sclerosis (ALS)

#7 | 2015-10-08

US20150284793A1

Chemistry; metallurgy

METHODS AND KITS FOR DIAGNOSING SCHIZOPHRENIA

#8 | 2015-09-17

US20150259392A1

Chemistry; metallurgy

Peptides for the treatment of neurodegenerative diseases

#9 | 2015-03-26

US20150086517A1

Human necessities

Mesenchymal stem cells for the treatment of CNS diseases

#10 | 2014-06-05

US20140154222A1

Chemistry; metallurgy

Isolated cells and populations comprising same for the treatment of CNS diseases

#11 | 2014-05-22

US20140140968A1

Chemistry; metallurgy

Mesenchymal stem cells for the treatment of CNS diseases

#12 | 2013-12-26

US20130344041A1

Chemistry; metallurgy

Genetically modified muscle cells which express neurotrophic factors

#13 | 2013-09-12

US20130236964A1

Chemistry; metallurgy

METHODS, NUCLEIC ACID CONSTRUCTS AND CELLS FOR TREATING NEURODEGENERATIVE DISORDERS

#14 | 2013-05-16

US20130123187A1

Chemistry; metallurgy

PEPTIDES FOR THE REGULATION OF NEUROTRANSMITTER SEQUESTRATION AND RELEASE

#15 | 2012-09-06

US20120225822A1

Chemistry; metallurgy

Peptides for the treatment of oxidative stress related disorders

#16 | 2012-01-12

US20120009673A1

Human necessities

Mesenchymal stem cells for the treatment of CNS diseases

#17 | 2011-09-01

US20110212896A1

Chemistry; metallurgy

Peptides for the treatment of oxidative stress related disorders

#18 | 2010-04-15

US20100093600A1

Chemistry; metallurgy

Peptides for the regulation of neurotransmitter sequestration and release

#19 | 2010-01-28

US20100021434A1

Chemistry; metallurgy

Isolated Oligodendrocyte-Like Cells and Populations Comprising Same for the Treatment of CNS Diseases

#20 | 2009-10-15

US20090257987A1

Chemistry; metallurgy

Method of generating dopamine-secreting cells

#21 | 2009-01-08

US20090010895A1

Human necessities

Isolated cells and populations comprising same for the treatment of CNS diseases

#22 | 2006-09-21

US20060211628A1

Human necessities

Treatment of multiple sclerosis with brain targeted anti oxidant compounds

#23 | 2005-12-01

US20050265983A1

Chemistry; metallurgy

Methods, nucleic acid constructs and cells for treating neurodegenerative disorders

InventorID:

249008 ⎘